Cargando…

Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma

PURPOSE: To report the results of stereotactic body radiotherapy (SBRT) for unresectable primary or recurrent cholangiocarcinoma. MATERIALS AND METHODS: From January 2005 through August 2013, 58 patients with unresectable primary (n = 28) or recurrent (n = 30) cholangiocarcinoma treated by SBRT were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Da Hoon, Kim, Mi-Sook, Cho, Chul Koo, Yoo, Hyung Jun, Jang, Won Il, Seo, Young Seok, Paik, Eun Kyung, Kim, Kum Bae, Han, Chul Ju, Kim, Sang Bum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194299/ https://www.ncbi.nlm.nih.gov/pubmed/25324988 http://dx.doi.org/10.3857/roj.2014.32.3.163

Ejemplares similares

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
por: Paik, Eun Kyung, et al.
Publicado: (2018)

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2016)

Feasibility of using stereotactic body radiation therapy for unresectable soft tissue tumors of the trunk
por: Paik, Eun Kyung, et al.
Publicado: (2018)

Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions
por: Bae, Sun Hyun, et al.
Publicado: (2015)

Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors
por: Cha, Yu Jin, et al.
Publicado: (2017)

Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis
por: Seo, Young‐Seok, et al.
Publicado: (2016)

High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
por: Jang, Won Il, et al.
Publicado: (2013)

Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma
por: Bae, Sun Hyun, et al.
Publicado: (2013)

Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2015)

A Survey of Stereotactic Body Radiotherapy in Korea
por: Bae, Sun Hyun, et al.
Publicado: (2015)

Long Term Follow-up Results of External Beam Radiotherapy as Primary Treatment for Retinoblastoma
por: Choi, Sang Yul, et al.
Publicado: (2010)

Stereotactic Body Radiotherapy for Isolated Para-aortic Lymph Node Recurrence after Curative Resection in Gastric Cancer
por: Kim, Mi-Sook, et al.
Publicado: (2009)

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
por: Borakati, Aditya, et al.
Publicado: (2022)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

The Clinical Status of Radiation Therapy in Korea in 2009 and 2013
por: Kang, Jin-Kyu, et al.
Publicado: (2016)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Clinical utilization of radiation therapy in Korea, 2016
por: Kim, Eunji, et al.
Publicado: (2020)

Current usage of stereotactic body radiotherapy for oligometastatic prostate cancer in Korea: patterns of care survey (KROG 19-08)
por: Bae, Sun Hyun, et al.
Publicado: (2021)

The clinical utilization of radiation therapy in Korea between 2009 and 2013
por: Kang, Jin-Kyu, et al.
Publicado: (2016)

The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015
por: Seo, Young-Seok, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
por: Mahadevan, Anand, et al.
Publicado: (2015)

Stereotactic radiotherapy in intrahepatic cholangiocarcinoma: A systematic review
por: Bisello, Silvia, et al.
Publicado: (2021)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
por: Kim, Hun Jung, et al.
Publicado: (2015)

Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2012)

Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study
por: Gil, Eunmi, et al.
Publicado: (2015)

Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy
por: Jeong, Songmi, et al.
Publicado: (2013)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
por: Lee, Eonju, et al.
Publicado: (2015)

Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine
por: Kim, Eunji, et al.
Publicado: (2023)

Correction: Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine
por: Kim, Eunji, et al.
Publicado: (2023)

Stereotactic Radiofrequency Ablation of an Unresectable Intrahepatic Cholangiocarcinoma (ICC): Transforming an Aggressive Disease into a Chronic Condition
por: Laimer, Gregor, et al.
Publicado: (2020)

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
por: KIM, MIN-JEONG, et al.
Publicado: (2013)

Multimodality treatment in unresectable cholangiocarcinoma
por: Aghili, Mahdi, et al.
Publicado: (2020)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
por: Kim, Young-Il, et al.
Publicado: (2013)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted
por: Talreja, Jayant P., et al.
Publicado: (2013)

Biliothorax in a patient with unresectable cholangiocarcinoma
por: Valero, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2hnsomflcscelqgesi8126dbss